Crestone, Inc. is a drug discovery and development company focused on developing novel treatments for serious bacterial infections. The company currently has two programs that address areas of significant and growing unmet medical need, both with novel mechanism of action agents. 1. Novel antibiotic for Clostridium difficile infections. CRS3123 (formerly known as REP3123) is in development fo...
Crestone, Inc. is a drug discovery and development company focused on developing novel treatments for serious bacterial infections. The company currently has two programs that address areas of significant and growing unmet medical need, both with novel mechanism of action agents. 1. Novel antibiotic for Clostridium difficile infections. CRS3123 (formerly known as REP3123) is in development for the treatment of C. difficile infection (CDI).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.